Employee-related Liabilities, Current of InMed Pharmaceuticals Inc. from 30 Jun 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
InMed Pharmaceuticals Inc. quarterly Employee-related Liabilities, Current in USD history and change rate from 30 Jun 2022 to 31 Dec 2025.
  • InMed Pharmaceuticals Inc. Employee-related Liabilities, Current for the quarter ending 31 Dec 2025 was $376,656, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Change (%)

InMed Pharmaceuticals Inc. Quarterly Employee-related Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $376,656 +$39,420 +12% 31 Dec 2025 10-Q 11 Feb 2026 2026 Q2
Q3 2025 $274,250 30 Sep 2025 10-Q 06 Nov 2025 2026 Q1
Q2 2025 $490,405 +$2,127 +0.44% 30 Jun 2025 10-Q 11 Feb 2026 2026 Q2
Q1 2025 $464,665 31 Mar 2025 10-Q 12 May 2025 2025 Q3
Q4 2024 $337,236 +$235,461 +231% 31 Dec 2024 10-Q 12 Feb 2025 2025 Q2
Q2 2024 $488,278 -$54,027 -10% 30 Jun 2024 10-K 23 Sep 2025 2025 FY
Q4 2023 $101,775 31 Dec 2023 10-Q 13 Feb 2024 2024 Q2
Q3 2023 $279,556 30 Sep 2023 10-Q 14 Nov 2023 2024 Q1
Q2 2023 $542,305 +$403,185 +290% 30 Jun 2023 10-Q 14 Nov 2023 2024 Q1
Q2 2022 $139,120 30 Jun 2022 10-K 29 Sep 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.